Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NKG2D CAR T-cells
i
Other names:
NKG2D CAR T-cells
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Shanghai Yake Biotech
Drug class:
NKG2D-targeted CAR-T immunotherapy
Related drugs:
‹
CD19/NKG2DL CAR-T Therapeutic (0)
CYAD-01 (0)
KD-025 CAR T-cells (0)
KD-496 (0)
CD19/NKG2DL CAR-T Therapeutic (0)
CYAD-01 (0)
KD-025 CAR T-cells (0)
KD-496 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.